Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
O-BMT for Opioid Use Disorder at Syringe Exchanges
NCT03150173Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2019
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in opioid use disorder (OUD) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Buprenorphine Engagement at 30 days. Started Jan 2019; status: completed.
02
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03150173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150173.